State Street’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-24,400
Closed -$14K – 3753
2016
Q3
$14K Hold
24,400
– – ﹤0.01% 3558
2016
Q2
$15K Sell
24,400
-823,792
-97% -$879K ﹤0.01% 3676
2016
Q1
$1.24M Buy
848,192
+155,708
+22% +$307K ﹤0.01% 3167
2015
Q4
$2.22M Sell
692,484
-1,523
-0.2% -$7.32K ﹤0.01% 2960
2015
Q3
$4.34M Buy
694,007
+96,467
+16% +$902K ﹤0.01% 2591
2015
Q2
$5.94M Buy
597,540
+121,992
+26% +$1.07M ﹤0.01% 2544
2015
Q1
$3.51M Buy
475,548
+79,045
+20% +$532K ﹤0.01% 2764
2014
Q4
$2.12M Buy
396,503
+53,860
+16% +$276K ﹤0.01% 3019
2014
Q3
$1.72M Buy
342,643
+14,698
+4% +$90.3K ﹤0.01% 3082
2014
Q2
$2.2M Buy
327,945
+315,345
+2,503% +$2.01M ﹤0.01% 3027
2014
Q1
$91K Buy
12,600
+600
+5% +$3.56K ﹤0.01% 3508
2013
Q4
$45K Hold
12,000
– – ﹤0.01% 3545
2013
Q3
$40K Hold
12,000
– – ﹤0.01% 3545
2013
Q2
$40K Buy
+12,000
New +$43.5K ﹤0.01% 3468

Other funds holding NWBO

State Street's NWBO Position: Q4 2016 in Review

State Street sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 24,400 shares — an estimated $14K sold.

State Street first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $5.94M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • State Street reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
  • State Street sold 24,400 Northwest Biotherapeutics shares in Q4 2016, an estimated $14K.
  • State Street first reported a position in Northwest Biotherapeutics in Q2 2013 and held it in 14 quarters.
  • State Street's Northwest Biotherapeutics position peaked at $5.94M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.

Based on State Street's 13F filing for Q4 2016, filed 9 Feb 2017.